Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant
暂无分享,去创建一个
A. Bowen | C. Blyth | Kristine Macartney | C. Glover | D. Burgner | N. Crawford | B. McMullan | Alison Boast | P. Britton | J. Francis | J. Clark | N. Wood | Nan Vasilunas | J. Carr | E. Carey | Laura López
[1] S. Ladhani,et al. Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2 , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] L. S. Schmidt,et al. Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave. , 2022, JAMA pediatrics.
[3] Kristine Macartney,et al. The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021 , 2022, The Medical journal of Australia.
[4] I. Shavit,et al. Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel. , 2022, JAMA.
[5] A. Randolph,et al. An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2 , 2021, The Pediatric infectious disease journal.
[6] H. Marshall,et al. Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study , 2021, BMJ Open.
[7] N. Dinsmore. Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious paediatric conditions. , 2021, Communicable diseases intelligence.
[8] M. H. Cheng,et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.